The Efficacy and Safety of Microvascular Decompression for Hemifacial Spasm in Elderly Patients.
- Author:
Chul Jin JEON
1
;
Doo Sik KONG
;
Jeong A LEE
;
Kwan PARK
Author Information
1. Department of Neurosurgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. kwanpark@skku.edu
- Publication Type:Original Article
- Keywords:
Microvascular decompression;
Hemifacial spasm;
Elderly patients
- MeSH:
Aged;
Anesthesia, General;
Cranial Nerves;
Facial Paralysis;
Female;
Hearing Loss;
Hemifacial Spasm;
Humans;
Male;
Microvascular Decompression Surgery;
Retrospective Studies
- From:Journal of Korean Neurosurgical Society
2010;47(6):442-445
- CountryRepublic of Korea
- Language:English
-
Abstract:
OBJECTIVE: The purpose of this study was to examine the efficacy and safety of microvascular decompression (MVD) for hemifacial spasm (HFS) in elderly patients. METHODS: Between 1997 and June 2008, 1,174 patients had undergone MVD for HFS at our institute. Among these, 53 patients were older than 65 years. We retrospectively reviewed and compared the complication and the cure rates of these patients with those of younger patients. RESULTS: There were 38 females and 15 males. The mean duration of symptoms of HFS of these patients was 94.6 months (range, 12-360 months), compared with 67.2 months (range, 3-360 months) in the younger group. The overall cure rate in elderly patients who underwent MVD for HFS during this period was 96.2%. Permanent cranial nerve dysfunctions, such as hearing loss and facial palsy, were seen in 2 patients (3.8%, 2/53) in the elderly group and 19 patients (1.7%, 19/1121) in the younger group. The difference in permanent cranial nerve dysfunction between the two groups was not statistically significant. There was no operative mortality in either group. CONCLUSION: Microvascular decompression is the most effective surgical modality available for the treatment of HFS. Results of this study indicate that such technique can be performed in the elderly without higher rates of morbidity or mortality. Any patient with HFS, whose general health is acceptable for undergoing general anesthesia, should be considered as a candidate for MVD.
